Tool to set and monitor targets for HIV prevention, diagnosis, treatment and care for key populations

World Health Organization (WHO)

TOOL DESCRIPTION


Supplement to the 2014 “Consolidated guidelines for HIV prevention, diagnosis, treatment and care for key populations”

Aim:
To provide guidance on monitoring and evaluating the implementation of the comprehensive package of interventions to address HIV among key populations.

Type of Document:
This document provides countries with: (1) a set of harmonized indicators to examine the implementation of the package of interventions to address HIV among key populations; and (2) guidance on setting targets for these indicators. The framework presented here is designed to help plan and assess progress at the macro level, in particular for national and subnational programming.

Audience Intended:
Countries planning and monitoring efforts to address HIV among key populations. This planning and assessment process should involve government agencies, nongovernmental organizations (NGOs), communities and service providers involved in developing, implementing, monitoring and evaluating HIV prevention, treatment and care programs for these key populations.

Populations Experiencing Stigma and/or Discrimination:
Men who have sex with men, people in prisons and other closed settings, people who inject drugs, sex workers and transgender people.

Stigma and/or Discrimination:
Both.

Assess and/or Address:
Address.

Implementation:
The framework presented here is designed to help plan and assess progress at the macro level, in particular for national and subnational programming. It goes beyond stigma and discrimination in health care settings but includes attention to these issues. The PLHIV Stigma Index is proposed as a way of assessing PLHIVs’ experiences of stigma as well as health providers’ attitudes. Attention is also given to the diversity of key populations and the need to ensure appropriate disaggregation of data e.g. by age, gender, geographic location and other ‘risk characteristics’.

Comments:
This document should be read in conjunction with the “consolidated guidelines”


← Back to All Tools